<DOC>
	<DOCNO>NCT01152723</DOCNO>
	<brief_summary>Single-dose pharmacokinetics two new oral nicotine replacement product Nicorette® gum .</brief_summary>
	<brief_title>Pharmacokinetics With Two New Oral Nicotine Replacement Products Nicorette® Gum</brief_title>
	<detailed_description>The study single-dose , randomize , cross-over study . The investigational product give single dos separate visit . The product administration comprise 30 minute chew . Periods without NRT , last least 36 hour , separate treatment visit . Before start product administration treatment visit , blood sample pharmacokinetic analysis , pre-dose , 8 hour start product administration . Used gum collect analyzed determine amount remain nicotine . Subjects also monitor capture adverse event may occur . Treatment label conceal subject study personnel .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy subject , smoke least 10 cigarette daily least one year precede inclusion BMI 17.5 30.0 kg/m2 . Female participant childbearing potential require use medically acceptable mean birth control . A personally sign date informed consent document , indicate subject inform pertinent aspect study . Pregnancy , lactation intend pregnancy . Treatment investigational product donation loss blood within 3 month precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Smoking Cessation , Nicotine pharmacokinetics</keyword>
</DOC>